Results 81 to 90 of about 27,665 (215)

Potential misinterpretation of treatment effects due to use of odds ratios and logistic regression in randomized controlled trials. [PDF]

, 2011
Background In randomized controlled trials (RCTs), the odds ratio (OR) can substantially overestimate the risk ratio (RR) if the incidence of the outcome is over 10%.
Pharmacoepidemiology, Duijnhoven, R.G., Groenwold, R.H.H., Knol, M.J., Grobbee, D.E., Moons, K.G.M., Sub Pharmacoepidemiology   +6 more
core   +1 more source

Previous bariatric surgery was not associated with an increased risk of reintervention within 2 years after knee arthroplasty: A nationwide register‐based study from Denmark

Knee Surgery, Sports Traumatology, Arthroscopy, EarlyView.
Abstract Purpose Obesity is a major risk factor for knee osteoarthritis (KOA). Bariatric surgery (BAS) effectively induces weight loss, but some of these patients subsequently require knee arthroplasty (KA) despite substantial weight reduction. However, the impact of prior BAS on the risk of reintervention, antibiotic use and mortality following KA ...
Saber Muthanna Aljuboori, Janne Petersen, Robin Christensen, Espen Jimenez‐Solem, Line Lund Kårhus, Søren Overgaard   +5 more
wiley   +1 more source

A Systematic Review of Potential Opioid Prescribing Safety Indicators

Pharmacoepidemiology
Background/Objectives: This systematic review aimed to identify a comprehensive list of potential opioid-related indicators from the published literature to assess prescribing safety in any setting.
Wael Y. Khawagi, Neetu Bansal, Nan Shang, Li-Chia Chen   +3 more
doaj   +1 more source

Rosuvastatin safety : a comprehensive, international pharmacoepidemiology programme

, 2006
Results from clinical trials and clinical practice have shown statins to be generally well tolerated with a low frequency of clinically relevant side effects. Nevertheless, there are rare occasions when adverse events (AEs), sometimes serious, may occur.
Walker, Alexander M., García Rodríguez, Luis A., Johansson, Saga,, Herings, Ron M. C., McAfee, Andrew T., Ming, Eileen E, González-Pérez, Antonio, Ming, Eileen E., Johansson, Saga, Herings, Ron M.C., Goettsch, Wim G., Wallander, Mari-Ann,   +11 more
core   +1 more source

Identification of cannabis use disorder using the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM‐5) versus DSM‐5‐proxy measures: Differences by socio‐demographic characteristics

Addiction, EarlyView.
Abstract Background and Aims Cannabis use disorder (CUD) is a pressing public health concern in the United States, and understanding trends in prevalence requires considerations of how changes in measurement influence identification of CUD. Starting in 2021, the National Survey on Drug Use and Health (NSDUH) assessed CUD using all 11 Diagnostic and ...
Evan L. Eschliman, Erin M. Annunziato, Nicole D. Fitzgerald, Pia M. Mauro   +3 more
wiley   +1 more source

Exploratory Signal Detection of Maternal and Perinatal Adverse ART Drug Events in EudraVigilance: Insights from Network and Cluster Analyses

Pharmacoepidemiology
Background: Medication safety in pregnancy, puerperium, and perinatal periods is underexplored because these populations are excluded from clinical trials.
Bárbara Costa, Nuno Vale
doaj   +1 more source

Improving appropriate medication use for older people in primary care [PDF]

, 2013
Clinical pharmacy interventions for older people with polypharmacy can be divided in dispensing services (aimed at support of medication management), e.g.
Pharmacoepidemiology, Kwint, H.F., Sub Pharmacoepidemiology   +2 more
core   +1 more source

Palbociclib in the Treatment of HR+/ HER2‐ Advanced or Metastatic Breast Cancer in Australia: A Real‐World Retrospective Analysis

Asia-Pacific Journal of Clinical Oncology, EarlyView.
This study investigated the real‐world use of CDK4/6 inhibitors in Australian patients with HR+/HER2‐ advanced or metastatic breast cancer, providing data on patient demographics, treatment patterns, and outcomes with palbociclib. ABSTRACT Background There is limited real‐world data on the use of CDK4/6 inhibitors in Australian patients with HR+/HER2 ...
Louise Nott, Eugene Moylan, Maree Colosimo, Giles Stratton, Thomas Chiu, Mahsa H. Kouhkamari, Maureen Hitschfeld, Jessica Michie, Richard De Boer   +8 more
wiley   +1 more source

Impact of Long-Term Statin Therapy on Influenza Incidence and Overall Mortality: A Real-World Data Analysis

Pharmacoepidemiology
Background/Objectives: The study’s goal is to assess the association between long-term statin therapy and influenza incidence, influenza severity, and all-cause mortality.
Diana Toledo, Àurea Cartanyà-Hueso, Constança Pagès-Fernández, Rosa Morros, Maria Giner-Soriano, Àngela Domínguez, Carles Vilaplana-Carnerero, Alba Tor-Roca, María Grau   +8 more
doaj   +1 more source

Advancing Health Equity in Europe: Explore, Tailor, Implement, and Evaluate (ETIE)-A Framework of Diversity and Fairness in Pharmacoepidemiologic Research.

Pharmacoepidemiology should represent and benefit populations equitably, embracing diversity and equity, and ensuring fairness. This article describes equity and fairness in pharmacoepidemiology, depicts key diversity domains, and provides an operational
de Vries, S.T., Mehta, I., Goswami, S., Ndem-Galbert, J.R., Soriano Gabarró, M., Clair, C., Korjagina, M., La Parra-Casado, D., Faquetti, M.L., Ida, F., Aubrun, E., Moga, D.C., Wested, J., Ochi, T., Martínez-González, M., Douros, A., Martinez-De La Torre, A., Marcus, A.F., Vallejo-Yagüe, E., Guedes, S., Gardarsdottir, H., van Valkengoed, I., Maso, A., Schumacher Dimech, A.M., Clamote Rodrigues, D., Nordeng, H., Korzh, O.   +26 more
core   +1 more source